The Finding of New In Vivo Metabolite Triptorelin (5-10) in Human Urine Using Liquid Chromatography Coupled with Ion Trap/Time-of-Flight Mass Spectrometry with Dimethyl Sulfoxide Additives in the Mobile Phase

• Published in: Molecules (Basel, Switzerland) Vol. 28; no. 12; p. 4572
• Main Authors: Saardpun, Navaporn, Songsaeng, Ruamsiri, Tanratana, Pansakorn, Kusamran, Thanit, Pinthong, Darawan
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.06.2023; MDPI
• Subjects: Antimitotic agents; Antineoplastic agents; Chromatography; Chromatography, Liquid - methods; Comparative analysis; Dimethyl Sulfoxide; doping; GnRH analogs; Gonadotropin-Releasing Hormone; Humans; Ions; LC/MS-IT-TOF; Leuprolide; leuprorelin detection; Liquid chromatography; Mass spectrometry; Metabolites; Peptides; Pituitary hormones; Prostate cancer; Scientific imaging; Tandem Mass Spectrometry - methods; triptorelin detection; triptorelin metabolite; Triptorelin Pamoate; Urine; Thailand; Australia; Israel; doping; leuprorelin detection; LC/MS-IT-TOF; triptorelin detection; triptorelin metabolite; GnRH analogs
• DOI: 10.3390/molecules28124572
• ISSN: 1420-3049

Triptorelin and leuprorelin are synthetic gonadotrophin-releasing hormones (GnRH) that are on the World Anti-Doping Agency (WADA) list of prohibited substances. To investigate the possible in vivo metabolites of triptorelin and leuprorelin in humans compared to previously reported in vitro metabolites, excreted urine from five patients treated with either triptorelin or leuprorelin was analyzed by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry (LC/MS-IT-TOF). The addition of dimethyl sulfoxide (DMSO) to the mobile phase was found to enhance the detection sensitivity of certain GnRH analogs. The method was validated, and the limit of detection (LOD) was found at 0.02−0.08 ng/mL. Using this method, a novel new metabolite of triptorelin was discovered in the urine of all subjects up to 1 month after triptorelin administration, but it was not observed in the urine of subjects before drug administration. The limit of detection was estimated to be 0.05 ng/mL. The structure of the metabolite, triptorelin (5-10), is proposed from bottom-up mass spectrometry analysis. The discovery of in vivo triptorelin (5-10) can possibly be used as supporting evidence of triptorelin misuse in athletes.